Dr Brittany McGill, B.PSYCH(HONS), M.PSYCH(CLIN)

Dr Brittany McGill is a Clinical Psychologist and Research Fellow at the Behavioural Sciences Unit, which is part of both UNSW Medicine & Health and the Sydney Children’s Hospital. She is passionate about improving psychosocial outcomes for families of children and young people impacted by serious illnesses (including genetic conditions), and helping patients to navigate new genomic technologies.

Dr Glenn Bennett, Genepath Chief Medical Officer & UNSW Research Fellow

Glenn is co-founder of Genepath and Research Fellow at the UNSW School of Population Health. His research interests are in population health science, in particular co-design of newborn screening models of care with advocacy groups.

A/Prof Bonny Parkinson

Bonny Parkinson is an Associate Professor at the Macquarie University Centre for the Health Economy, which is part of both the Macquarie Business School and the Australian Institute of Health Innovation. Her research interests include pharmaceutical policy in Australia, researching economic evaluation of healthcare interventions and technologies methodology, and analysing linked administrative data to inform economic evaluations.

Dr Varinder Jeet

Dr Varinder Jeet is an established health economist passionate about improving healthcare systems and promoting equitable access to quality medical services. He works for the Macquarie University Centre for the Health Economy, a part of the Australian Institute of Health Innovation and Macquarie Business School. Varinder is interested in economic modelling for therapeutic interventions, genetic testing/clinical genomics, cancer studies, and equity and public policy research.

Dr. Kobus Ungerer, Director Chemical Pathology, Pathology Queensland

Kobus Ungerer oversees the Chemical Pathology service for the public sector in Queensland, including the Newborn Screening unit. His research interests span several areas within laboratory medicine, with a strong focus on translating research into clinical practice. He is currently leading the implementation of a novel Targeted Gene Sequencing technology aimed at expanding the Newborn Screening program.

Dr Carel Pretorius, Pathologist, Chemical Pathology, Pathology Queensland

Carel Pretorius is a senior chemical pathologist at Pathology Queensland and holds an associate professor position at the University of Queensland. His primary focus is on clinical biochemistry, and he has contributed to a better understanding of biochemical processes and advances in diagnostic methods, particularly in the context of metabolic disorders. He is passionate about translating state-of-the-art diagnostic methods, such as targeted gene sequencing, into routine clinical practice.

Dr Carolyn Mazariego

Dr Carolyn Mazariego is an early career implementation scientist and health services researcher. She specialises in implementation strategy design, process mapping, co-design/creation, and hybrid trials. Under the guidance of A/Prof. Taylor, Dr Mazariego will lead the targeted genomic NBS implementation strategy design.

A/Prof. Natalie Taylor

A/Prof. Natalie Taylor is a senior implementation scientist and health services researcher. A/Prof. Taylor is pioneering a combination of implementation research with statistical modelling and health economics to test the cost-effectiveness of implementation interventions and explore ways to identify the active ingredients behind successful implementation of new treatments, technologies, policies, and guidelines. She is the Principal Chief Investigator on the MRFF targeted genomic NBS grant.